Skip to main content

Animations

MJFF Publications

8091 - 8100 of 9030 Results
Title
Year
  • Year
  • 2020
  • 2018
  • 2021
  • 2018
  • 2025
  • 2021
  • 2020
  • 2026
  • 2021
  • 2024
  • Summary Details
    OPEN
    Title: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28382
    Citation Count: 23
  • Animal models of l‐dopa‐induced dyskinesia in Parkinson's disease
    2018
    Summary Details
    OPEN
    Title: Animal models of l‐dopa‐induced dyskinesia in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27337
    Citation Count: 0
  • Summary Details
    OPEN
    Title: LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells10020203
    Citation Count: 1
  • Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains
    2018
    Summary Details
    RESTRICTED
    Title: Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.016
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70028
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-85293-4
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.03.021
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Discordance of Dopaminergic Dysfunction and Subcortical Atrophy by α‐Synuclein Status in Sporadic and Genetic Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70186
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The PINK1—Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0259903
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Detecting the symptoms of Parkinson’s disease with non-standard video
    Journal Name: Journal of NeuroEngineering and Rehabilitation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12984-024-01362-5
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.